TKT and prostate adenocarcinoma: Thymidine kinase was not used in a therapeutic capacity in this model although a previous report had shown therapeutic responses with 5-fluorocytosine and valganciclovir treatment when administered in combination with cytosine deaminase, HSV-TK and IL-12 in a TRAMP-C2 prostate adenocarcinoma model38.